β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

Archive ouverte

Puymirat, Etienne | Riant, Elisabeth | Aissoui, Nadia | Soria, Angèle | Ducrocq, Gregory | Coste, Pierre | Cottin, Yves | Aupetit, Jean | Bonnefoy, Eric | Blanchard, Didier | Cattan, Simon | Steg, Gabriel | Schiele, François | Ferrières, Jean | Juillière, Yves | Simon, Tabassome | Danchin, Nicolas

Edité par CCSD ; BMJ Publishing Group -

International audience. OBJECTIVETo assess the association between early and prolonged beta blocker treatment and mortality after acute myocardial infarction.DESIGNMulticentre prospective cohort study.SETTINGNationwide French registry of Acute ST- and non-STelevation Myocardial Infarction (FAST-MI) (at 223 centres) at the end of 2005.PARTICIPANTS2679 consecutive patients with acute myocardial infarction and without heart failure or left ventricular dysfunction.MAIN OUTCOME MEASURESMortality was assessed at 30 days in relation to early use of beta blockers (<= 48 hours of admission), at one year in relation to discharge prescription, and at five years in relation to one year use.RESULTSbeta blockers were used early in 77% (2050/2679) of patients, were prescribed at discharge in 80% (1783/2217), and were still being used in 89% (1230/1383) of those alive at one year. Thirty day mortality was lower in patients taking early beta blockers (adjusted hazard ratio 0.46, 95% confidence interval 0.26 to 0.82), whereas the hazard ratio for one year mortality associated with beta blockers at discharge was 0.77 (0.46 to 1.30). Persistence of beta blockers at one year was not associated with lower five year mortality (hazard ratio 1.19, 0.65 to 2.18). In contrast, five year mortality was lower in patients continuing statins at one year (hazard ratio 0.42, 0.25 to 0.72) compared with those discontinuing statins. Propensity score and sensitivity analyses showed consistent results.CONCLUSIONSEarly beta blocker use was associated with reduced 30 day mortality in patients with acute myocardial infarction, and discontinuation of beta blockers at one year was not associated with higher five year mortality. These findings question the utility of prolonged beta blocker treatment after acute myocardial infarction in patients without heart failure or left ventricular dysfunction.

Consulter en ligne

Suggestions

Du même auteur

Factors Associated with Infarct-related Artery Patency before Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction (From the FAST-MI 2010 Registry)

Archive ouverte | Bailleul, Clotilde | CCSD

International audience. Early infarct-related artery (IRA) patency is associated with better clinical outcomes in patients with ST-elevation myocardial infarction (STEMI). Using the French Registry of ST-elevation a...

Acute Myocardial Infarction

Archive ouverte | Puymirat, Etienne | CCSD

International audience. BACKGROUND: ST-segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI) management has evolved considerably over the past 2 decades. Little ...

Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-STelevation Myocardial Infarction) programme

Archive ouverte | Puymirat, Etienne | CCSD

International audience. Aims The use of opioids is recommended for pain relief in patients with myocardial infarction (MI) but may delay antiplatelet agent absorption, potentially leading to decreased treatment effi...

Chargement des enrichissements...